Preclinical Toxicology of Small Molecule Drugs Developed for Cancer and Other Indications
Closed Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest special notice from .
- Solicitation number
- 75N91021R00003
- Agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- USA
Notice details come from SAM.gov. Updated .
Notice text
6 versions
Update #6 · Latest ·
Please see attached Amendment 5- 75N91021R00003.
Update #5 ·
Please see attached Amendment 4- 75N91021R00003.
Update #4 ·
Please see attached Amendment 3- 75N91021R00003.
Update #3 ·
Please see attached Amendment 2- 75N91021R00003.
Update #2 ·
Please see attached Amendment 1- 75N91021R00003.
Update #1 ·
Please see attached documents related to Solicitation No: 75N91021R00003, titled "Preclinical Toxicology of Small Molecule Drugs Developed for Cancer and Other Indications".
Files
Show all 14
Notice history
| Notice | Type | Posted |
|---|---|---|
| Preclinical Toxicology of Small Molecule Drugs Developed for Cancer and Other Indications | Award Notice | |
| Preclinical Toxicology of Small Molecule Drugs Developed for Cancer and Other Indications | Special Notice | |
| This notice | Solicitation | |
| Preclinical Toxicology of Small Molecule Drugs Developed for Cancer and Other Indications | Pre-Solicitation | |
| Preclinical Toxicology of Small Molecule Drugs Developed for Cancer and Other Indications | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity